Henry Schein Inc (HSIC) Stock Price & Analysis
Henry Schein Inc (HSIC) rose 1.11% to USD 85.47 as of July 25, 2026 at 02:21 UTC, according to Nexqual real-time market data.
HSIC last closed at USD 84.53; the session ranged USD 84.43–86.01 on volume of 1,068,928 shares. Market capitalization is $9.74B, with a 52-week range of USD 61.95–89.34 (NMS). Source: Nexqual, July 25, 2026 at 02:21 UTC.
Key Statistics (as of July 25, 2026 at 02:21 UTC)
| Price | USD 85.47 |
|---|---|
| Change | ▲ 1.11% (up) |
| Previous Close | USD 84.53 |
| Open | USD 84.53 |
| Day Range | USD 84.43 – 86.01 |
| 52-Week Range | USD 61.95 – 89.34 |
| Volume | 1,068,928 shares |
| Market Cap | $9.74B |
| Exchange | NMS |
Technical Analysis (HSIC)
Nexqual's technical model rates HSIC "BUY" based on 4 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 02:21 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 56.62 (neutral) |
| vs SMA50 | Above (USD 80.46) |
| MACD | 1.37 (positive) |
Analyst Ratings (HSIC)
Wall Street analysts rate HSIC "None" based on 16 analysts, with a mean price target of USD 88.5 (range USD 64–100), per Nexqual as of July 25, 2026 at 02:21 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 16 |
| Mean Target | USD 88.5 |
| High Target | USD 100 |
| Low Target | USD 64 |
| Buy / Hold / Sell | 9 / 7 / 1 |
Earnings (HSIC)
| Next Earnings Date | 2026-08-04 |
|---|---|
| EPS Estimate | USD 1.24 |
| Revenue Estimate | $3.37B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 1.32 vs est 1.22 ▲ beat |
| 2025-12-31 | USD 1.34 vs est 1.29 ▲ beat |
| 2025-09-30 | USD 1.38 vs est 1.28 ▲ beat |
| 2025-06-30 | USD 1.1 vs est 1.19 ▼ miss |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Financials & Fundamentals (HSIC)
| Total Revenue | $13.38B |
|---|---|
| Revenue Growth (YoY) | +6.30% |
| Gross Margin | +31.19% |
| Operating Margin | +5.85% |
| Profit Margin | +2.95% |
| ROE | +8.76% |
| Debt / Equity | 77.75 |
| Current Ratio | 1.36 |
| Total Cash | $138.00M |
| Total Debt | $3.75B |
| Free Cash Flow | $290.12M |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Financial Health Score (HSIC)
Nexqual rates Henry Schein Inc's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 02:21 UTC.
| Growth | Mixed — Revenue +4.0% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 31%, operating 6% |
| Balance Sheet | Mixed — $138M cash vs $3.75B debt |
| Cash Flow | Mixed — FCF $290M, slim 2.2% margin |
| Efficiency | Mixed — ROE 9%, ROA 4.4% |
Ownership (HSIC)
| Insider Ownership | +0.82% |
|---|---|
| Institutional Ownership | +108.21% |
| Shares Outstanding | 113.92M |
| Float | 93.88M |
| Short % of Float | +7.55% |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Leadership (HSIC)
Henry Schein Inc is led by Andrea Albertini (age 55), Chief Executive Officer of Global Distribution & Technology, per Nexqual as of July 25, 2026 at 02:21 UTC.
| Chief Executive Officer of Global Distribution & Technology | Andrea Albertini (age 55) |
|---|---|
| Senior VP & CFO | Ronald N. South (age 63) |
| Executive VP & COO | Michael Saul Ettinger (age 64) |
| CEO & Director | Frederick M. Lowery (age 54) |
| Senior VP & CTO | Christopher Pendergast (age 62) |
Major Backers & Investors (HSIC)
Notable institutional backers of Henry Schein Inc include Kohlberg Kravis Roberts & Co. L.P., Invesco, Artisan Partners Limited Partnership, according to Nexqual as of July 25, 2026 at 02:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Kohlberg Kravis Roberts & Co. L.P. | 13.74% |
| Invesco | 6.32% |
| Artisan Partners Limited Partnership | 5.77% |
| FMR, LLC | 5.02% |
| American Century Companies Inc | 4.47% |
| JPMorgan | 4.01% |
| J.P. Morgan Fleming Mutual Fd. Group, Inc.-JPMorgan Mid Cap Value Fd. | 1.48% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 17.5% |
| BlackRock | 7.33% |
| State Street | 3.84% |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
From Henry Schein Inc's Latest SEC 10-K Filing (filed 2026-02-24)
Key Strengths & Strategy (as disclosed to the SEC)
- Our infrastructure, including over 5.4 million square feet of space in 38 strategically located distribution centers and 0.6 million square feet of space in 17 manufacturing facilities around the world, enables us to historically provide rapid and accurate order fulfillment, better serve our customers and increase our operating efficiency.
- Within Global Technology, we compete against numerous dental software providers, including the Eaglesoft division of Patterson Companies, Inc., Carestream Dental LLC, Centaur Software Development Co Pty Ltd. (d.b.a. dental4windows, dental4web), Open Dental Software, Inc., PlanetDDS LLC, Good Methods Global Inc. (d.b.a.
- We offer a broad range of products, including the Henry Schein corporate brand, and services to our customers at competitive prices, in the following categories: Global Distribution and Value-Added Services • Consumable merchandise and equipment.
- Furthermore, Section 361 of the Public Health Service Act, which provides authority to prevent the introduction, transmission or spread of communicable diseases, serves as the legal basis for the United States Food and Drug Administration's ("FDA") regulation of human cells, tissues and cellular and tissue-based products, also known as "HCT/P products." The Federal Drug Quality and Security Act of 2013 regulates pharmaceutical supply chain requirements and pre- empts certain state laws.
Partnerships
- In collaboration with leading clinicians, our research and development teams drive innovation to enhance patient care.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| XRAY | DENTSPLY SIRONA Inc. | USD 12.93 | ▼ 2.56% |
| COO | The Cooper Companies, Inc. | USD 70.31 | ▼ 0.27% |
| UHS | Universal Health Services, Inc. | USD 155.75 | ▲ 4.29% |
| MTD | Mettler-Toledo International, I | USD 1,327.18 | ▲ 3.21% |
| CHRW | C.H. Robinson Worldwide, Inc. | USD 186.51 | ▼ 10.05% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:21 UTC. This page is informational and not investment advice.